Clinical Trials in Phoenix

Showing 4421-4440 of 16,646 trials

18F-AV-1451 High Resolution Autopsy Study

NCT02350634

The study is designed to examine the relationship between imaging results detected on a 18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.

Alzheimer's Disease

Avid Radiopharmaceuticals3 participantsStarted Nov 2016

Phoenix, Arizona, United States • San Francisco, California, United States

Active Not Recruiting< 1 mile

Alzheimer's Plasma Extension

NCT06416072

The APEX study is a multicenter, observational study designed to capture longitudinal follow-up of plasma biomarkers and cognitive and functional assessments on individuals who screen failed in the AHEAD study over approximately 4 years. Approximately 1000 participants will be enrolled across three groups: * Group A: Approximately 500 participants who are discordant on screening (plasma positive / Positron Emission Tomography (PET) negative), * Group B: Approximately 250 participants who are concordant on screening (plasma negative / PET negative), and * Group C: Approximately 250 participants selected from the individuals who previously screen failed prior to PET for the AHEAD study with oversampling of racial and ethnic populations underrepresented in Alzheimer's disease (AD) clinical trials. Primary Objectives: * Collect longitudinal cognitive and functional assessments and blood-based biomarker data * Evaluate, characterize, and compare the longitudinal cognitive and functional data between the three groups of participants * Compare longitudinal change across race and ethnicity, sex, and Apolipoprotein E (ApoE) status Exploratory Objectives: • Collect baseline amyloid PET on participants without prior amyloid PET data (Group C)

Preclinical Alzheimer's DiseaseEarly Preclinical Alzheimer's Disease

University of Southern California1,000 participantsStarted Sep 2023

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sun City, Arizona, United States +53 more locations

18F-AV-1451 High Resolution Autopsy Study

Alzheimer's Plasma Extension

Find Trials by Condition in Phoenix

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study

Electrical Nerve Block for Amputation Pain

Observational Study - TA- 2025-1

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

Study to Evaluate Safety and Immunogenicity of a Prime-Boost Regimen of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

Medical Access Program for Patritumab Deruxtecan

A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1)

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer

Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001

Promoting Shared Decision Making for Severe Aortic Stenosis

A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Incidence of HIV Infection in Screening Indian Men Who Have Sex With Men